Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cora Therapeutics logo — Dedicated to delivering and supporting innovative research-b...

Cora Therapeutics

Dedicated to delivering and supporting innovative research-based wellness solutions for whole body health

Founded 2015 Canada Toronto, Canada 3 employees Seed Total: $1.80M Biotechnology, Health Care +1

General Information

Company Name Cora Therapeutics
Founded Year 2015
Location Canada Toronto, Canada
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Cora Therapeutics. To contact Cora Therapeutics, visit coratherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cora Therapeutics compare?

A PDF of Cora Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cora Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cora Therapeutics

Cora Therapeutics is a biotechnology and healthcare startup based in Canada, dedicated to delivering innovative research-based wellness solutions for whole body health. Led by Dr. Kieran Murphy, the company's slogan, "Dedicated to delivering and supporting innovative research-based wellness solutions for whole body health," encapsulates its mission. Dr. Murphy's personal experience, having lost colleagues to diseases linked to long-term occupational radiation exposure, inspired the development of the company's flagship product, Halo, in 2011. This antioxidant formulation aims to prevent cellular and mitochondrial damage from oxidative stress. In March 2023, the company secured a significant milestone with a $1.80M Seed Round investment from IronGate Capital Advisors. This injection of capital provides Cora Therapeutics the resources to advance its research and expand its market presence. Overall, Cora Therapeutics emerges as a promising player at the intersection of biotechnology and healthcare, with a clear focus on addressing unmet needs in radiation exposure and whole body health.

Business keywords: wellness solutions, research-based, whole body health, radiation exposure, antioxidant formulation, mitochondrial damage, oxidative stress, Dr. Kieran Murphy, occupational health, medical research, innovation, startup, health technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.80M 1
IronGate Capital Advisors
IronGate Capital Advisors
27 Mar 2023

Cora Therapeutics Alternatives & Competitors

View All Alternatives
Cora Therapeutics vs
Retrotope
Retrotope

Pioneering a novel drug platform to safeguard and rejuvenate mitochondrial health in degenerative di...

Series D
Biotechnology, Health Care
Cora Therapeutics vs
KPAX Health
KPAX Health United States

Patented Mitochondrial Support Backed by 20 Years of Research.

Venture round
4 employees
Biotechnology, Health Care
Compare Cora Therapeutics vs KPAX Health
Cora Therapeutics vs
Wake Network
Wake Network Canada

Advancing the field of fungi & plant medicine.

Series A
15 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cora Therapeutics

Dedicated to delivering and supporting innovative research-based wellness solutions for whole body health
Cora Therapeutics was founded in 2015.
Cora Therapeutics is headquartered in Toronto, Canada.
Cora Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on wellness solutions, research-based, whole body health and radiation exposure.
Cora Therapeutics has approximately 3 employees.
Cora Therapeutics has completed 1 funding round, raising a total of $1.80M. The latest funding stage is Seed.
Top alternatives and competitors to Cora Therapeutics include Retrotope, KPAX Health, Wake Network, Otonomy, Inc, Olivia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cora Therapeutics and Retrotope are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cora Therapeutics, https://bouncewatch.com/company/cora-therapeutics, updated 19 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout